Literature DB >> 18811234

Effective host response to Francisella tularensis requires functional mast cells.

Thomas J Cremer1, Susheela Tridandapani.   

Abstract

Evaluation of: Ketavarapu JM, Rodriguez AR, Yu J et al.: Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc. Natl Acad. Sci. USA 105(27), 9313-9318 (2008). The intracellular pathogen Francisella tularensis is a highly infectious organism that infects cells of the immune system. Mast cells have been known for their role in anaphylaxis, although they are also important for their ability to aid in the defense against pathogens. The report by Ketavarapu et al. has demonstrated that mast cells function to limit the replication of F. tularensis live vaccine strain within macrophages in vitro as well as in vivo. It was determined that IL-4 is one secreted mediator of this effect thus highlights a previously unknown mechanism of host defense against F. tularensis.

Entities:  

Year:  2008        PMID: 18811234      PMCID: PMC2572753          DOI: 10.2217/17460913.3.5.503

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  22 in total

1.  In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies.

Authors:  D A Leiby; A H Fortier; R M Crawford; R D Schreiber; C A Nacy
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice.

Authors:  Murugesan V S Rajaram; Latha P Ganesan; Kishore V L Parsa; Jonathan P Butchar; John S Gunn; Susheela Tridandapani
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma.

Authors:  Marina Santic; Maelle Molmeret; Yousef Abu Kwaik
Journal:  Cell Microbiol       Date:  2005-07       Impact factor: 3.715

Review 4.  Mast cells in the development of adaptive immune responses.

Authors:  Stephen J Galli; Susumu Nakae; Mindy Tsai
Journal:  Nat Immunol       Date:  2005-02       Impact factor: 25.606

5.  Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

Authors:  J Wayne Conlan; Rhonda KuoLee; Hua Shen; Ann Webb
Journal:  Microb Pathog       Date:  2002-03       Impact factor: 3.738

6.  The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

7.  Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.

Authors:  Jyothi M Ketavarapu; Annette R Rodriguez; Jieh-Juen Yu; Yu Cong; Ashlesh K Murthy; Thomas G Forsthuber; M Neal Guentzel; Karl E Klose; Michael T Berton; Bernard P Arulanandam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

8.  Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; John S Gunn; Larry S Schlesinger; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-06-02       Impact factor: 4.407

9.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.

Authors:  R Malaviya; T Ikeda; E Ross; S N Abraham
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

10.  Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP.

Authors:  Kishore V L Parsa; Latha P Ganesan; Murugesan V S Rajaram; Mikhail A Gavrilin; Ashwin Balagopal; Nrusingh P Mohapatra; Mark D Wewers; Larry S Schlesinger; John S Gunn; Susheela Tridandapani
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.